Cilta-cel, Talquetamab — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-31 in 2mo
ESTIMATED |
READOUT
A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Partic
Phase 2 · Multiple Myeloma |
Janssen Research & Development, LL | Cilta-cel, Talquetamab |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|